NFKB1 and metabolic dysfunction-associated steatohepatitis: This activates the toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) signaling pathway and causes an inflammatory response in the liver, and inhibition of the inflammatory response by regulating the bacterial groups effectively improved NAFLD and NASH (16).